Cargando…

Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529244/ https://www.ncbi.nlm.nih.gov/pubmed/26252715 http://dx.doi.org/10.1371/journal.pone.0135547

Ejemplares similares

A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients
por: Braun, Dominique L., et al.
Publicado: (2015)

Correction: Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation
por: McClure, Janela, et al.
Publicado: (2012)

Correction: Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya
por: Kerubo, Glennah, et al.
Publicado: (2015)

HIV/Hepatitis B Coinfection Is Usually Treated Together. Is Hepatitis B Forgotten?
por: Giwa, Bashirat, et al.
Publicado: (2017)

Correction: Clostridium difficile outcomes difficult to generalize
por: Nagella, Naresh, et al.
Publicado: (2014)

Lung Cancer Management with Silibinin: A Historical and Translational Perspective
por: Verdura, Sara, et al.
Publicado: (2021)

Inhibitory effect of silibinin on hepatitis B virus entry
por: Umetsu, Teruyuki, et al.
Publicado: (2018)

HIV and Hepatitis C Virus Coinfection, Cameroon
por: Laurent, Christian, et al.
Publicado: (2007)

Hepatitis B coinfection in HIV-infected patients
por: Jugănariu, Gabriela, et al.
Publicado: (2013)

Update on Hepatitis C Virus and HIV Coinfection
por: Gemtessa, Tilahun Amdissa, et al.
Publicado: (2013)

Detecting spatial clusters of HIV and hepatitis coinfections
por: Das, Suparna, et al.
Publicado: (2018)

Publisher Correction: Silibinin, A Natural Blend In Polytherapy Formulation For Targeting Cd44v6 Expressing Colon Cancer Stem Cells
por: Patel, Shanaya, et al.
Publicado: (2018)

A fatal case of triple coinfection: COVID-19, HIV and Tuberculosis
por: Ortiz-Martínez, Yeimer, et al.
Publicado: (2021)

Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected Patients
por: Engell, Christian A., et al.
Publicado: (2011)

Correction: Cyclophosphamide Alters the Gene Expression Profile in Patients Treated with High Doses Prior to Stem Cell Transplantation
Publicado: (2014)

Correction: Predicting Carriers of Ongoing Selective Sweeps without Knowledge of the Favored Allele
por: Ronen, Roy, et al.
Publicado: (2016)

Author Correction for Hochman et al., Fatal Pediatric Cerebral Malaria Is Associated with Intravascular Monocytes and Platelets That Are Increased with HIV Coinfection
por: Hochman, Sarah E., et al.
Publicado: (2016)

Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy
por: Neukam, Karin, et al.
Publicado: (2015)

Effects of silibinin on hepatic warm ischemia-reperfusion injury in the rat model
por: Akbari-Kordkheyli, Vahid, et al.
Publicado: (2019)

Correction: A comment on priors for Bayesian occupancy models
por: Northrup, Joseph M., et al.
Publicado: (2019)

Management of Chronic Hepatitis B in HIV-Coinfected Patients
por: Fasano, Massimo, et al.
Publicado: (2022)

Correction: Sequence-Specific Targeting of Dosage Compensation in Drosophila Favors an Active Chromatin Context
por: Alekseyenko, Artyom A., et al.
Publicado: (2014)

Quantification of hepatic FOXP3+ T‐lymphocytes in HIV/hepatitis C coinfection
por: Williams, S. K., et al.
Publicado: (2014)

Correction: Gene Expression Ratios Lead to Accurate and Translatable Predictors of DR5 Agonism across Multiple Tumor Lineages
por: Reddy, Anupama, et al.
Publicado: (2016)

Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation
por: McClure, Janela, et al.
Publicado: (2012)

The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms
por: Musazadeh, Vali, et al.
Publicado: (2022)

Correction: The Ecological Conditions That Favor Tool Use and Innovation in Wild Bottlenose Dolphins (Tursiops sp.)
por: Patterson, Eric M., et al.
Publicado: (2011)

Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B
por: Lv, Duo-Duo, et al.
Publicado: (2021)

Correction: Diagonal symmetrizers for hyperbolic operators with triple characteristics
por: Nishitani, Tatsuo
Publicado: (2021)

Correction: Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

1603 Increased Risk of Hip Fracture Associated with Dually-Treated HIV/Hepatitis B Virus Coinfection
por: Lo Re, Vincent, et al.
Publicado: (2014)

Efficacy and tolerability of telaprevir (TVR)-based triple therapy in HIV/HCV-coinfected patients
por: De Los Santos, Ignacio, et al.
Publicado: (2014)

Meningococcemia in a patient coinfected with hepatitis C virus and HIV.
por: Nelson, C G, et al.
Publicado: (2000)

Hepatitis C treatment initiation in HIV-HCV coinfected patients
por: Cotte, Laurent, et al.
Publicado: (2016)

Correction: UVB Radiation as a Potential Selective Factor Favoring Microcystin Producing Bloom Forming Cyanobacteria
por: Ding, Yi, et al.
Publicado: (2014)

Correction: High Diversity in Cretaceous Ichthyosaurs from Europe Prior to Their Extinction
por: Fischer, Valentin, et al.
Publicado: (2014)

Managing chronic hepatitis C in the difficult-to-treat patient
por: Kemmer, Nyingi, et al.
Publicado: (2007)

Wound Healing Activity of Silibinin in Mice
por: Samanta, Rojalini, et al.
Publicado: (2016)

Silibinin: an old drug for hematological disorders
por: Zou, Hai, et al.
Publicado: (2017)

Silibinin and non-melanoma skin cancers
por: Prasad, Ram Raj, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n6l94vd0dn2eilhsr7fj2ufmfb